In conclusion, our data demonstrated that Nox2 deficiency attenuates cardiac sympathetic nerve terminal abnormalities, myocyte atrophy, myocyte autophagy, myocyte apoptosis and myocardial fibrosis and ameliorates cardiac atrophy and dysfunction in doxorubicin cardiomyopathy. Here, CYBB is linked to Myocardial fibrosis.